Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by scarlet1967on May 30, 2021 4:37pm
148 Views
Post# 33294438

RE:RE:RE:RE:RE:RE:THTX Weekly Report Card

RE:RE:RE:RE:RE:RE:THTX Weekly Report CardThe message has been delivered multiple times for a long time because of multiple emails from many posters to the company and they do follow this board, why should we think the message would be clearer if only one member would have been voted off. If we wanted to make an impact more than one member should have been voted off. Folks who voted for or against the board can’t be happy with the current valuation but as a reminder this is the board which by majority of votes approved a dreadful deal right after the good PR. The agenda of creating shareholder wealth should be on ongoing basis the problem is this board so far has neglected the valuation discrepancies, now one is hoping their plan to re-engineer the company is real and there is a sense of urgency from the company for that plan to be put in action as they have fallen behind the competition so far that many issues such as addressing the capital market, shareholder communication etc. needed to be fixed yesterday.
<< Previous
Bullboard Posts
Next >>